SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-000132
Filing Date
2023-01-03
Accepted
2023-01-03 16:30:37
Documents
12
Period of Report
2023-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33738
  Complete submission text file 0001493152-23-000132.txt   206589

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imnn-20230103.xsd EX-101.SCH 3221
3 XBRL LABEL FILE imnn-20230103_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE imnn-20230103_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3608
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 23502533
SIC: 2834 Pharmaceutical Preparations